Top

Published in:

01-11-2017 | Molecular Imaging

Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma

Authors: Hao Yu, Huiling Lou, Tianyu Zou, Xianlong Wang, Shanshan Jiang, Zhongqing Huang, Yongxing Du, Chunxiu Jiang, Ling Ma, Jianbin Zhu, Wen He, Qihong Rui, Jianyuan Zhou, Zhibo Wen

Published in: European Radiology | Issue 11/2017

Abstract

Objectives

To determine the utility of amide proton transfer-weighted (APTw) MR imaging in distinguishing solitary brain metastases (SBMs) from glioblastomas (GBMs).

Methods

Forty-five patients with SBMs and 43 patients with GBMs underwent conventional and APT-weighted sequences before clinical intervention. The APTw parameters and relative APTw (rAPTw) parameters in the tumour core and the peritumoral brain zone (PBZ) were obtained and compared between SBMs and GBMs. The receiver-operating characteristic (ROC) curve was used to assess the best parameter for distinguishing between the two groups.

Results

The APTw_max, APTw_min, APTw_mean, rAPTw_max, rAPTw_min or rAPTw_mean values in the tumour core were not significantly different between the SBM and GBM groups (P = 0.141, 0.361, 0.221, 0.305, 0.578 and 0.448, respectively). However, the APTw_max, APTw_min, APTw_mean, rAPTw_max, rAPTw_min or rAPTw_mean values in the PBZ were significantly lower in the SBM group than in the GBM group (P < 0.001). The APTw_min values had the highest area under the ROC curve 0.905 and accuracy 85.2% in discriminating between the two neoplasms.

Conclusion

As a noninvasive imaging method, APT-weighted MR imaging can be used to distinguish SBMs from GBMs.

Key Points

• APTw values in the tumour core were not different between SBMs and GBMs.

• APTw values in peritumoral brain zone were lower in SBMs than in GBMs.

• The APTw _min was the best parameter to distinguish SBMs from GBMs.

Wang X, Chen JX, Zhou Q et al (2016) Statistical report of central nervous system tumors histologically diagnosed in the Sichuan Province of China from 2008 to 2013: a West China Glioma Center Report. Ann Surg Oncol. doi:10.1245/s10434-016-5410-1 CrossRefPubMedPubMedCentral

Ostrom QT, Gittleman H, Fulop J et al (2015) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro-Oncology 17:v1–iv62CrossRef

Blanchet L, Krooshof PW, Postma GJ et al (2011) Discrimination between metastasis and glioblastoma multiforme based on morphometric analysis of MR images. AJNR Am J Neuroradiol 32:67–73CrossRef

Yuh WT, Engelken JD, Muhonen MG, Mayr NA, Fisher DJ, Ehrhardt JC (1992) Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. AJNR Am J Neuroradiol 13:335–345PubMed

Owonikoko TK, Arbiser J, Zelnak A et al (2014) Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol 11:203–222CrossRef

Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492–507CrossRef

Lee EJ, Ahn KJ, Lee EK, Lee YS, Kim DB (2013) Potential role of advanced MRI techniques for the peritumoural region in differentiating glioblastoma multiforme and solitary metastatic lesions. Clin Radiol 68:e689–e697CrossRef

Han CK, Huang SM, Guo JF, Zhuang XJ, Han HW (2015) Use of a high b-value for diffusion weighted imaging of peritumoral regions to differentiate high-grade gliomas and solitary metastases. J Magn Reson Imaging 42:80–86CrossRef

Abe T, Mizobuchi Y, Sako W et al (2015) Clinical significance of discrepancy between arterial spin labeling images and contrast-enhanced images in the diagnosis of brain tumors. Magn Reson Med Sci 14:313–319CrossRef

10.

Caivano R, Lotumolo A, Rabasco P et al (2013) 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature. Int J Neurosci 123:537–543CrossRef

11.

Mouthuy N, Cosnard G, Abarca-Quinones J, Michoux N (2012) Multiparametric magnetic resonance imaging to differentiate high-grade gliomas and brain metastases. J Neuroradiology Journal de neuroradiologie 39:301–307CrossRef

12.

Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PC (2003) Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 50:1120–1126CrossRef

13.

Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC (2003) Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 9:1085–1090CrossRef

14.

van Zijl PCM, Yadav NN (2011) Chemical exchange saturation transfer (CEST): what is in a name and what Isn't? Magn Reson Med 65:927–948CrossRef

15.

Jiang SS, Yu H, Wang XL et al (2016) Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla. Eur Radiol 26:64–71CrossRef

16.

Zhou J, Zhu H, Lim M et al (2013) Three-dimensional amide proton transfer MR imaging of gliomas: initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging 38:1119–1128CrossRef

17.

Togao O, Kessinger CW, Huang G et al (2013) Characterization of lung cancer by amide proton transfer (APT) imaging: an in-vivo study in an orthotopic mouse model. Plos One 8:e77019CrossRef

18.

Wen ZB, Hu SG, Huang FH et al (2010) MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast. Neuroimage 51:616–622CrossRef

19.

Togao O, Hiwatashi A, Yamashita K et al (2016) Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging. Eur Radiol. doi:10.1007/s00330-016-4328-0:1-11 CrossRefPubMed

20.

Sakata A, Okada T, Yamamoto A et al (2015) Grading glial tumors with amide proton transfer MR imaging: different analytical approaches. J Neuro-Oncol 122:339–348CrossRef

21.

Jia G, Abaza R, Williams JD et al (2011) Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging 33:647–654CrossRef

22.

Klomp DWJ, Dula AN, Arlinghaus LR et al (2013) Amide proton transfer imaging of the human breast at 7T: development and reproducibility. NMR Biomed 26:1271–1277CrossRef

23.

Dula AN, Arlinghaus LR, Dortch RD et al (2013) Amide proton transfer imaging of the breast at 3 T: Establishing reproducibility and possible feasibility assessing chemotherapy response. Magn Reson Med 70:216–224CrossRef

24.

Wang J, Weygand J, Hwang KP et al (2016) Magnetic resonance imaging of glucose uptake and metabolism in patients with head and neck cancer. Scientific reports 6:30618CrossRef

25.

Yuan J, Chen S, King AD et al (2014) Amide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer. NMR Biomed 27:1239–1247CrossRef

26.

Zhou JY, Tryggestad E, Wen ZB et al (2011) Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 17:130–U308CrossRef

27.

Ma B, Blakeley JO, Hong X et al (2016) Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas. J Magn Reson Imaging 44:456–462CrossRef

28.

Tietze A, Blicher J, Mikkelsen IK et al (2014) Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI. NMR Biomed 27:163–174CrossRef

29.

Tee YK, Harston GWJ, Blockley N et al (2014) Comparing different analysis methods for quantifying the MRI amide proton transfer (APT) effect in hyperacute stroke patients. NMR Biomed 27:1019–1029CrossRef

30.

Zhao XN, Wen ZB, Huang FH et al (2011) Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T. Magn Reson Med 66:1033–1041CrossRef

31.

Li CM, Peng S, Wang R et al (2014) Chemical exchange saturation transfer MR imaging of Parkinson's disease at 3 Tesla. Eur Radiol 24:2631–2639CrossRef

32.

Zhang Y, Heo HY, Lee DH et al (2016) Selecting the reference image for registration of CEST series. J Magn Reson Imaging 43:756–761CrossRef

33.

Zhang H, Kang H, Zhao X et al (2016) Amide proton transfer (APT) MR imaging and magnetization transfer (MT) MR imaging of pediatric brain development. Eur Radiol 26:3368–3376CrossRef

34.

Allen JS, Bruss J, Brown CK, Damasio H (2005) Normal neuroanatomical variation due to age: the major lobes and a parcellation of the temporal region. Neurobiol Aging 26:1245–1260CrossRef

35.

Tan Y, Wang XC, Zhang H et al (2015) Differentiation of high-grade-astrocytomas from solitary-brain-metastases: comparing diffusion kurtosis imaging and diffusion tensor imaging. Eur J Radiol 84:2618–2624CrossRef

36.

Crisi G, Orsingher L, Filice S (2013) Lipid and macromolecules quantitation in differentiating glioblastoma from solitary metastasis: a short-echo time single-voxel magnetic resonance spectroscopy study at 3 T. J Comput Assist Tomogr 37:265–271CrossRef

37.

Lee EJ, terBrugge K, Mikulis D et al (2011) Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. AJR Am J Roentgenol 196:71–76CrossRef

38.

Ramalho J, Castillo M, AlObaidy M et al (2015) High signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted MR images: evaluation of two linear gadolinium-based contrast agents. Radiology 276:836–844CrossRef

39.

Collidge TA, Thomson PC, Mark PB et al (2007) Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 245:168–175CrossRef

40.

Lemee JM, Clavreul A, Aubry M et al (2015) Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis. J Neuro-Oncol 122:53–61CrossRef

41.

Oh J, Cha S, Aiken AH et al (2005) Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging 21:701–708CrossRef

42.

Goplen D, Bougnaud S, Rajcevic U et al (2010) Alpha B-Crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells. Am J Pathol 177:1618–1628CrossRef

43.

Parney IF, Waldron JS, Parsa AT (2009) Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation Journal of neurosurgery 110:572–582PubMed

44.

Frieboes HB, Zheng X, Sun CH, Tromberg B, Gatenby R, Cristini V (2006) An integrated computational/experimental model of tumor invasion. Cancer Res 66:1597–1604CrossRef

45.

Fazi B, Felsani A, Grassi L et al (2015) The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors. Oncotarget 6:22526–22552CrossRef

Title: Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma
Authors: Hao Yu
Huiling Lou
Tianyu Zou
Xianlong Wang
Shanshan Jiang
Zhongqing Huang
Yongxing Du
Chunxiu Jiang
Ling Ma
Jianbin Zhu
Wen He
Qihong Rui
Jianyuan Zhou
Zhibo Wen
Publication date: 01-11-2017
Publisher: Springer Berlin Heidelberg
Published in: European Radiology / Issue 11/2017
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-017-4867-z

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma

Abstract

Objectives

Methods

Results

Conclusion

Key Points

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusion

Key Points

Please log in to get access to this content

Other articles of this Issue 11/2017

Prognostic implication of the metastatic lesion-to-ovarian cancer standardised uptake value ratio in advanced serous epithelial ovarian cancer

Do we need 3D tube current modulation information for accurate organ dosimetry in chest CT? Protocols dose comparisons

Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy

Retrosplenial cortical thinning as a possible major contributor for cognitive impairment in HIV patients

An evaluation of patient experience during percutaneous breast biopsy

Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis